Compugen shares ended last week at $11.60 but surged this week to challenge decade highs; the Israel-based biotech will raise nearly $60M in the offering, but at a punishing price to y new shareholders who bought into this week’s strength.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs